Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor γ2 subunit
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Agonists of the allosteric benzodiazepine site of GABAA receptors bind at the interface of the alpha and gamma subunits. Here, we tested the in vivo contribution of the gamma2 subunit to the actions of zolpidem, an alpha1 subunit selective benzodiazepine agonist, by generating mice with a phenylalanine (F) to isoleucine (I) substitution at position 77 in the gamma2 subunit. The gamma2F77I mutation has no major effect on the expression of GABAA receptor subunits in the cerebellum. The potency of zolpidem, but not that of flurazepam, for the inhibition of [3H]flunitrazepam binding to cerebellar membranes is greatly reduced in gamma2I77/I77 mice. Zolpidem (1 microM) increased both the amplitude and decay of miniature inhibitory postsynaptic currents (mIPSCs) in Purkinje cells of control C57BL/6 (34% and 92%, respectively) and gamma2F77/F77 (20% and 84%) mice, but not in those of gamma2F77I mice. Zolpidem tartrate had no effect on exploratory activity (staircase test) or motor performance (rotarod test) in gamma2I77/I77 mice at doses up to 30 mg/kg (i.p.) that strongly sedated or impaired the control mice. Flurazepam was equally effective in enhancing mIPSCs and disrupting performance in the rotarod test in control and gamma2I77/I77 mice. These results show that the effect of zolpidem, but not flurazepam, is selectively eliminated in the brain by the gamma2F77I point mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944
Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550
Differences in Synaptic GABAA Receptor Number Underlie Variation in GABA Mini Amplitude
Nusser, Z., Cull-Candy, S., & Farrant, M. (1997) · Neuron · doi:10.1016/s0896-6273(00)80382-7 · Cited by 449 · cited 4×
“The values of mIPSC parameters in stellate/basket cells under control conditions between the two groups of mice were not significantly different (c2F77/F77 n 1⁄4 8 cells from four mice; c2I77/I77 n 1⁄4 9 cells from three mice, unpaired t-test) and were similar to those observed in previous studies (Llano and Marty, 19…”
BackgroundResultInfluential
Cited by
Remote Control of Neuronal Signaling
Rogan, S. C., & Roth, B. L. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003020 · Cited by 339
GABA A Receptor-Mediated Tonic Inhibition in Thalamic Neurons
Cope, D. W., Hughes, S. W., & Crunelli, V. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3362-05.2005 · Cited by 312
Self-citationUygun, D. S., Ye, Z., Zecharia, A. Y., Harding, E. C., Yu, X., Yustos, R., Vyssotski, A. L., Brickley, S. G., Franks, N. P., & Wisden, W. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3714-15.2016 · Cited by 48
“Consequently, knock-in mice with the 2 point mutation 2F77I ( 2I77lox mice) are behaviorally insensitive to zolpidem in the dose range 1–30 mg/kg (Cope et al., 2004; Wulff et al., 2007; Leppä et al., 2011).”
BackgroundSelf-citationLeppä, E., Linden, A.-M., Vekovischeva, O. Y., Swinny, J. D., Rantanen, V., Toppila, E., Höger, H., Sieghart, W., Wulff, P., Wisden, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024159 · Cited by 30
Self-citationMontégut, L., Rousseau, A., Ungolo, C., Derosa, L., Fidelle, M., Alves Costa Silva, C., Routy, B., Zitvogel, L., Besse, B., Pasolli, E., et al. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2528955 · Cited by 8
“22,25 27–30 Mice bearing this mutation in homozygosity (genotype: Gabrg2 F77I/F77I ) bear a similar phenotype as mice subjected to the conditional knockout of Dbi or receiving systemic injections of anti-DBI mAb.”
Metadata
- Authors
- Cope, D. W., Wulff, P., Oberto, A., Aller, M. I., Capogna, M., Ferraguti, F., Halbsguth, C., Hoeger, H., Jolin, H. E., Jones, A., Mckenzie, A. N. J., Ogris, W., Poeltl, A., Sinkkonen, S. T., Vekovischeva, O. Y., Korpi, E. R., Sieghart, W., Sigel, E., Somogyi, P., & Wisden, W.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 47
- Issue
- 1
- Pages
- 17-34
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2116772816
- Cited by
- 71
- References
- 4
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor γ2 subunit. https://app.cochat.ai/papers/10.1016/j.neuropharm.2004.03.007
- The paper
- Cope, D. W., Wulff, P., Oberto, A., Aller, M. I., Capogna, M., Ferraguti, F., Halbsguth, C., Hoeger, H., Jolin, H. E., Jones, A., Mckenzie, A. N. J., Ogris, W., Poeltl, A., Sinkkonen, S. T., Vekovischeva, O. Y., Korpi, E. R., Sieghart, W., Sigel, E., Somogyi, P., & Wisden, W. (2004). Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor γ2 subunit. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2004.03.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.